General Information of the Compound
| Compound ID |
CP0778905
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(R)-3-(3-Hexylsulfanyl-pyrazin-2-yloxy)-1-aza-bicyclo[2.2.1]heptane hydrochloride
Show/Hide
|
||||||||||||||||||
| Synonyms |
WAY-132983
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C16H26ClN3OS
|
||||||||||||||||||
| Molecular Weight |
343.924
|
||||||||||||||||||
| Canonical SMILES |
CCCCCCSc1nccnc1O[C@H]1CN2CCC1C2.Cl
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C16H25N3OS.ClH/c1-2-3-4-5-10-21-16-15(17-7-8-18-16)20-14-12-19-9-6-13(14)11-19;/h7-8,13-14H,2-6,9-12H2,1H3;1H/t13?,14-;/m0./s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
QAXRREHLPKHWBI-IJDFPQMLSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound
Drug 1 ( WAY-132983 )
| Drug Name | WAY-132983 | ||
|---|---|---|---|
| Target(s) |
Muscarinic acetylcholine receptor M1 (CHRM1)
Agonist
|
||